IRIS
RASI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.886
AS - Asia 3.874
EU - Europa 3.003
SA - Sud America 531
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 34.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.765
SG - Singapore 1.973
CN - Cina 867
IT - Italia 514
BR - Brasile 454
UA - Ucraina 411
DE - Germania 398
RU - Federazione Russa 356
HK - Hong Kong 314
IE - Irlanda 282
PL - Polonia 264
FR - Francia 255
VN - Vietnam 248
GB - Regno Unito 147
KR - Corea 118
SE - Svezia 118
FI - Finlandia 114
JP - Giappone 114
CA - Canada 72
NL - Olanda 57
BD - Bangladesh 51
IN - India 51
AR - Argentina 31
MX - Messico 27
UZ - Uzbekistan 20
AT - Austria 19
ID - Indonesia 15
EC - Ecuador 14
IQ - Iraq 14
ZA - Sudafrica 14
ES - Italia 13
TR - Turchia 12
BE - Belgio 10
IR - Iran 10
CL - Cile 9
PK - Pakistan 9
VE - Venezuela 9
EU - Europa 8
MA - Marocco 8
SA - Arabia Saudita 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
PH - Filippine 7
CO - Colombia 6
CZ - Repubblica Ceca 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
LT - Lituania 5
RO - Romania 5
CH - Svizzera 4
CR - Costa Rica 4
JM - Giamaica 4
KE - Kenya 4
OM - Oman 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DM - Dominica 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 34.357
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.568
Wilmington 7.094
Houston 5.920
Singapore 801
Ann Arbor 757
Fairfield 622
Ashburn 476
Jacksonville 382
San Jose 373
Chandler 354
Beijing 325
Hong Kong 305
Dublin 277
Kraków 251
Seattle 240
Medford 225
Cambridge 224
Dearborn 155
Santa Clara 132
The Dalles 119
Rome 110
Lawrence 99
New York 96
Los Angeles 95
Tokyo 91
Dallas 86
Hangzhou 78
Ho Chi Minh City 74
Zhengzhou 73
Hanoi 67
Council Bluffs 66
Buffalo 63
Mülheim 63
Milan 50
San Diego 47
Moscow 43
Lauterbourg 41
Porto Alegre 36
São Paulo 35
Helsinki 30
Boardman 28
Chicago 28
Toronto 27
Menlo Park 25
London 24
Shanghai 24
Munich 22
Nuremberg 22
Haiphong 20
Falls Church 19
Hefei 19
University Park 18
Columbus 17
Frankfurt am Main 17
Nanjing 17
Verona 17
Chennai 16
Rio de Janeiro 15
San Mateo 15
Norwalk 14
Orem 14
Belo Horizonte 13
Montreal 13
North Bergen 13
Redwood City 13
Yongsan-gu 13
Atlanta 12
Bologna 12
Brooklyn 12
Warsaw 12
Denver 11
Kunming 11
Mountain View 11
San Francisco 11
Seoul 11
Johannesburg 10
Fukuoka 9
Guangzhou 9
Jakarta 9
Tashkent 9
Brussels 8
City of London 8
Curitiba 8
Da Nang 8
Detroit 8
Miami 8
Tampa 8
Washington 8
Amsterdam 7
Boston 7
Chengdu 7
Goiânia 7
Nürnberg 7
Palo Alto 7
Redondo Beach 7
Saint Petersburg 7
Vienna 7
Brasília 6
Brno 6
Florence 6
Totale 28.720
Salva come PNG Salva come JPEG
Nome #
Thymosin alpha 1: from bench to bedside 629
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 578
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 555
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 540
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 535
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 505
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 502
Survivin-Igm Immuno Complex: A Novel Candidate Biomarker Of Cirrhosis To Monitor Patients Progression Towards Hepatocellular Carcinoma 500
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety 487
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 485
Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling 484
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 479
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 469
The risks of risk aversion in drug regulation 468
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 467
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 464
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union 464
Access to patient-level trial data--a boon to drug developers 464
Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma 457
Anti-tumour immunogens and vaccines 452
Combination therapy with BRMs in cancer and infectious diseases 447
Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy 445
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 443
Treatment of aspergillus infection with thymosin alpha 1 443
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling 442
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 439
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 438
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 436
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 430
High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma 425
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 423
An audience with Guido Rasi. Interview by Asher Mullard 422
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C 420
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 418
Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo 416
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 411
Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts 405
up-regulation of melanocytic differentiation antigens induced by cyanidin-3-o--glucopyranoside in human melanoma cells. 405
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response 404
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS-K AND PRODUCTION OF INFECTIOUS VIRUS-LIKE PARTICLES IN HUMAN MELANOMA CELLS ABS -0153 401
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional healthcare providers 399
Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model 397
Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside 395
Straight talk with...Guido Rasi. Interview by Roxanne Khamsi 394
early detection of molecular markers suitable for colorectal cancer diagnosis and therapy in a carcinogenesis model 393
Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma 390
nerve growth factor (ngf) and cirrhosis: a possible new marker of progression to hepatocellular carcinoma (hcc) 389
differentiation therapy: in vitro evidence making cyanidin-3-o--glucopiranoside useful for prevention and treatment of melanoma 389
Fifty years after thalidomide; what role for drug regulators? 389
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee 389
null 385
COMPARATIVE CELLULAR SIGNAL PATWAY ANALYSIS OF METASTATIC COLORECTAL CANCER IN HUMAN AND PRECLINICAL ANIMAL MODEL 383
null 380
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. 380
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice 376
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha 1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery 376
Method of up-regulating tumor antigen expression using thymalfasin 375
Preclinical studies using oncofidä-s, a new sn38-hyaluronic acid bioconyugate, for cd44-targeted therapy of colon carcinoma 374
Influenza della concentrazione di adriamicina su modificazioni volumetriche e proliferazione di cellule leucemiche in vitro 373
Characterization of four newly established melanoma cell lines 369
preventive peptide vaccine for colorectal cancer metastases 368
up-regulation of melan-a/mart-1 antigen expression during human melanoma cell differentiation 367
Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms 362
nerve growth factor (ngf): a possible marker for hepatocellular carcinoma (hcc)? 358
null 342
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer 332
Stimolazione in vivo mediante prostaglandine ed interferone dell'attività natural killer in topi trattati con ciclofosfamide. vol. 87, p. 595-603 320
Rationale for therapeutic approaches with thymic hormones, interleukin 2 and interferon in combination with chemotherapy. 318
A new tumour associated antigen of non-small cell lung cancer: Tumour Liberated Proteins (TLP) - A possible new tumor marker 265
Metformin induces apoptosis and downregulates pyruvate kinase M2 in breast cancer cells only when grown in nutrient-poor conditions 259
A new tumour associated antigen of non-small cell lung cancer: Tumour liberated proteins (TLP) - A possible new tumor marker 231
Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase-II controlled trial 218
Sequential biochemotherapy for metastatic colorectal cancer using, fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects 197
BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS 196
Open clinical trial data for all? A view from regulators 195
Clinical trial publications: A sufficient basis for healthcare decisions? 176
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation 172
Asthma, allergy and the olympics: A 12-year survey in elite athletes 172
From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients 158
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 151
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 146
Big Data – How to Realize the Promise 144
Preliminary evidence of the differential expression of human endogenous retroviruses in Kawasaki disease and SARS-CoV-2-associated multisystem inflammatory syndrome in children 141
Innovative medicines: New regulatory procedures for the third millennium 135
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice 129
Transparency and the European medicines agency - Sharing of clinical trial data 128
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? 127
First-in-human clinical trials - What we can learn from tragic failures 126
European regulatory experience with drugs for central nervous system disorders 121
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations 121
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 121
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward 120
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 119
preventive peptide vaccine for colorectal cancer metastases 116
Drug regulation and pricing - Can regulators influence affordability? 107
Steps forward in regulatory pathways for acute and chronic heart failure 105
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 104
Inhibitor of fatty acid amide hydrolase: learning from tragic failures [The editorialists reply] 103
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).] 92
Characterization of three melanoma cell lines (TVM-A12, TVM-A-197, TVM-BO): Sensitivity to lysis and effect of retinoic acid 91
Totale 33.745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022977 32 113 45 26 24 92 77 38 94 67 57 312
2022/20231.150 127 53 45 120 91 292 97 79 81 12 129 24
2023/2024317 40 8 31 18 30 67 11 11 2 11 13 75
2024/20252.991 69 585 319 136 51 223 121 145 256 245 441 400
2025/20263.762 320 173 449 256 334 101 416 539 447 430 157 140
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 34.568